Reading this on a mobile device? Try our optimized mobile version here:

December 6, 2012
Sign upForwardArchiveAdvertise
News for nuclear medicine and molecular imaging professionals
The news summaries appearing in SNMMI SmartBrief are based on original information from multiple internet sources and are produced by SmartBrief, Inc., an independent e-mail newsletter publisher. The items below are not selected or reviewed by SNMMI prior to publication. Questions and comments may be directed to SmartBrief at

  Top Story 
  • SNMMI to give education credits at upcoming meeting
    SNMMI said it will be giving doctors, physicists and pharmacists the chance to obtain up to 36.75 continuing education credits at its midwinter meeting. The group said it will also allow for up to 36.5 hours of Verification of Involvement in Continuing Education credits for nuclear medicine technologists at the meeting in New Orleans. (free registration) (12/5) LinkedInFacebookTwitterEmail this Story
Every patient is UNIQUE.
So why should they all receive the same PET dose? The MEDRAD™ Intego™ PET Infusion System makes personalization practical. Clinicians can determine and administer a personalized minimum acceptable dose for each patient from a simple touch screen. To see how the MEDRAD™ Intego™ is enabling better patient care, click here.
  Clinical News & Research 
  • PET MPI boosts risk prediction in coronary disease
    A mildly abnormal stress rubidium-82 PET MPI test is linked to a 2.3 times higher risk of cardiac death compared with a normal test, indicating that PET MPI screening can boost the accuracy of risk determination in patients with coronary disease, according to a study published in the Journal of the American College of Cardiology. The study reviewed outcomes from 7,061 patients at four centers. The evaluation of the extent of ischemia and scar added to cardiac death risk reclassification in one in every nine patients in the study who had clinical PET MPI, researchers said. (Montreal)(free registration) (12/5) LinkedInFacebookTwitterEmail this Story
  Industry Report 
  • Molecular medicine institute to focus on pediatric diseases
    Phoenix Children's Hospital is set to unveil the Ronald A. Matricaria Institute of Molecular Medicine in January. The institute will specialize in cancer therapies for children and will eventually include other pediatric diseases. The institute has already entered into partnerships with the University of Arizona College of Medicine in Phoenix and the Translational Genomics Research Institute. Modern Healthcare (subscription required) (12/5) LinkedInFacebookTwitterEmail this Story
  News from the Field 
  • Emory, Alliance establish imaging center in Ga.
    Alliance HealthCare Services and Emory Healthcare have established a new diagnostic imaging center in Buford, Ga. "Our partnership with Alliance will allow Emory to provide a wide array of state-of-the-art imaging capabilities to better serve the metro-Atlanta community," Emory Hospital Midtown CEO Dane Peterson said. Alliance Imaging specializes in MRI, PET/CT and CT services. Modern Physician(free registration) (12/5) LinkedInFacebookTwitterEmail this Story
  International Developments 
  • Venus to undertake Phase III trials of cancer imaging agent
    Venus Remedies has obtained approval from the Drugs Controller General of India to undertake Phase III clinical trials of its new chemical entity VRP1620, designed for the detection of early cancer and of benign and malignant tumors. VRP1620 works by boosting tumor blood flow, which aids in the delivery of contrast agents for tumors through the bloodstream. The company is looking to introduce the agent to domestic and international markets by the end of 2013. The Economic Times (India)/Press Trust of India (12/5) LinkedInFacebookTwitterEmail this Story
  Health Policy 
  • Lawmaker proposes mobile, wireless health bill
    Rep. Mike Honda, D-Calif., has proposed a bill that would aim to form a mobile health system initiative at HHS and eliminate obstacles to wireless health adoption. The legislation also looks at the development of a tax incentive program that would help providers cut their costs associated with non-EHR health IT activities and calls for the FDA to develop an Office of Wireless Health. Healthcare Informatics online (12/4) , (12/4) LinkedInFacebookTwitterEmail this Story
  Advancing Health Care 
  From SNMMI 
  • Renew your SNMMI membership for 2013!
    Renew your membership today and continue to take advantage of SNMMI's extensive member benefits, including the world's No. 1 medical imaging journal — The Journal of Nuclear Medicine — along with continuing education opportunities and great member discounts. Renew today. LinkedInFacebookTwitterEmail this Story
  • Robert E. Henkin Government Relations Fellowship submission deadline is Dec. 31
    Submit your application for the Robert E. Henkin Government Relations Fellowship. Nuclear medicine is a highly regulated profession, and it is essential for its leaders to have first-hand understanding of regulatory challenges. This fellowship will provide gifted, highly motivated young nuclear and molecular imaging professionals with first-hand experience in the process of health policy development. Application deadline is Dec. 31. LinkedInFacebookTwitterEmail this Story
SNMMI  |  News  |  Meetings  |  Education  |  Publications  |  Membership

SNMMI on Facebook  |  SNMMI on LinkedIn  |  SNMMI on Twitter  |  SNMMI on YouTube

To change one's life: Start immediately. Do it flamboyantly. No exceptions."
--William James,
American psychologist and philosopher

LinkedInFacebookTwitterEmail this Story

Subscriber Tools
Print friendly format  | Web version  | Search past news  | Archive  | Privacy policy

Account Director:   Meryl Harold   (202) 407-7828
 Recent SNMMI SmartBrief Issues:   Lead Editor:   Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2012 SmartBrief, Inc.®  Legal Information